Uncategorized

The AI-enabled device can report screenings it determines are normal without radiologist review.

The company is working through a backlog after the cyberattack hampered manufacturing, order processing and shipping.

A problem with the leads could cause inadequate stimulation, Boston Scientific said. In the worst case, leads may need to be removed or replaced.

After nearly tripling its contract ceiling with the VA, Congress wants to hear from Oracle’s Executive Chairman Larry Ellison and CEO Mike Sicilia about the project’s escalating costs and lengthy timeline.

With M&A rising, venture capital returning and policy risks easing, biotech is on a positive trajectory following a prolonged post-pandemic slump, Truist Securities declared after a survey of sector leaders.

Seven of the 10 companies participating in the fall cohorts of MassBio and SCbio’s Drive program are based in the United States, including four in Massachusetts.

Pressured by federal antitrust concerns, Fairfield Medical Center has completed a merger with Adena Health after pivoting from a planned sale to state giant OhioHealth.

The co-development deal comes after Pfizer reported a late-stage failure for a Seagen asset and the discontinuation of another investigational therapy developed by the company as a subsidiary of the pharma.

AbbVie’s etentamig has a relatively cleaner safety profile and an administration schedule that could give it an edge over other BCMA-targeting multiple myeloma therapies on the market, according to BMO Capital Markets.

Este último, más pequeño que la Tierra y el planeta más cercano al Sol, probablemente comenzó a enfriarse muy pronto: cuando tan solo habían transcurrido unos mil millones de años tras su formación, la actividad volcánica de Mercurio ces …